100011 This application is a U.S. national stage application of International Patent Application No. PCT/EP2018/0055945, filed Mar. 9, 2018, which claims the benefit of GB Application No. 1703771.4, filed Mar. 9, 2017, and GB Application No. 1703772.2, filed Mar. 9, 2017, the disclosure of each of which is hereby incorporated by reference in its entirety.
This disclosure relates to apparatus for imaging blood within a target region of tissue and a corresponding method of imaging blood within a target region of tissue.
Wound healing is natural process performed by the human body in response to injury. The amount of time taken for a wound to heal is dependent on many different factors which include the human body's ability to heal itself and any treatments that are applied to the wound to accelerate wound healing. Understanding the healing status of a wound and being able to monitor the healing process helps to inform decisions on further treatment of the wound and can also assist in the development of future wound therapies.
One factor that is known to be associated with wound healing is the amount of blood supplied to blood vessels within tissue at or near a wound. The process of supplying blood to blood vessels within tissue is known as blood perfusion. Oxygen and nutrients carried by blood within wounded tissue are essential for wound healing and so the amount of oxygenated blood within tissue is known to correlate well with wound healing. Conventional techniques for determining the presence of blood within skin tissue include near-infrared imaging to determine oxygen saturation of blood vessels within tissue at or near a wound.
Typically, such techniques require specialised equipment that is both bulky and expensive. Techniques for imaging blood within tissue can be hampered by reflection of illuminating light by the upper surface of the tissue.
It is an aim of the present disclosure to at least partly mitigate the above-mentioned problems.
It is an aim of certain embodiments of the present disclosure to provide a means for imaging blood within tissue that can utilise a light source that provides illumination using visible light having a broad spectral range.
It is an aim of certain embodiments of the present disclosure to mitigate the effect of illuminating light which does not penetrate tissue on images obtained of blood within the tissue.
It is an aim of certain embodiments of the present disclosure to provide a means for imaging blood within tissue such that blood perfusion within the tissue can be assessed.
According to some embodiments, there is provided apparatus for imaging blood within a target region of tissue, comprising: an imaging device configured to output image data associated with light received by the imaging device having a first spectral range and configured to output image data associated with light received by the imaging device having a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; and a controller or controlling element configured to capture the image data associated with light received by the imaging device having the first spectral range and image data associated with light received by the imaging device having the second spectral range contemporaneously and to process the captured image data associated with light having the first spectral range and the captured image data associated with light having the second spectral range to generate compound image data associated with an amount of blood within the target region of tissue.
The imaging device may comprise an imaging sensor comprising a plurality of sensor elements, wherein each sensing element is configured to output data associated with the amount of light received by the sensing element at the first spectral range and to output data associated with the amount of light received by the sensing element at the second spectral range.
The plurality of sensor elements may be arranged in a two-dimensional array. The imaging sensor may comprise a digital imaging sensor. The digital imaging sensor may comprise a complementary metal-oxide semiconductor image sensor or a charge-couple device imaging sensor.
The controlling element may be configured to record a first value associated with the amount of light received by each sensing element at the first spectral range and a second value associated with the amount of light received by each sensing element at the second spectral range.
The controlling element may be further configured to generate a compound value associated with each sensing element based on the first value and the second value. The compound value may be a difference between the first value and the second value. The controlling element may be configured to apply a scaling factor to the first value and/or second value when generating the compound value.
The apparatus may further comprise a digital display unit, wherein the controlling element is configured to display a digital image comprising a plurality of pixels on the display, wherein each pixel is associated with at least one of the sensing elements and each pixel has a value based on the compound value associated with each respective sensing element.
The digital image may have a predefined brightness and/or colour scale based on which the compound values for each sensing element are represented.
The first spectral range may correspond to a spectral range associated with red light. The second spectral range may correspond to a spectral range associated with green light.
The apparatus may further comprise a light source configured to provide illuminating light having the first spectral range and to provide illuminating light having the second spectral range.
The light source may be configured to provide illuminating light having a spectral range which encompasses the first spectral range and the second spectral range. The light source may comprise at least one light emitting diode.
According to some embodiments, there is provided a method of imaging blood within a target region of tissue comprising the steps of: capturing image data associated with at least a portion of a target region of tissue at a first spectral range; capturing image data associated with at least the portion of a target region of tissue at a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range, wherein the image data associated with at least a portion of a target region of tissue at a first spectral range and the image data associated with at least the portion of a target region of tissue at a second spectral range are captured contemporaneously; and processing the image data captured at the first spectral range and the image data captured at the second spectral range to generate compound image data associated with an amount of blood within the target tissue.
The step of capturing image data at the first spectral range and the step of capturing image data at the second spectral range may comprise capturing image data using an imaging sensor comprising a plurality of sensor elements to capture image data associated with the amount of light received by each sensing element at each of the first spectral range and the second spectral range.
The step of processing the image data captured at the first spectral range and the image data captured at the second spectral range may comprise the step of comparing a first value associated with the amount of light received by each sensing element at the first spectral range and a second value associated with the amount of light received by each sensing element at the second spectral range.
The step of processing the image data captured at the first spectral range and the image data captured at the second spectral range may comprise the step of generating a compound value associated with each sensing element based on the first value and the second value. The compound value may be a difference between the first value and the second value.
The method may further comprise the step of applying a scaling factor to the first value and/or second value when generating the compound value.
The method may further comprise the step of at least one of displaying, storing and transmitting the compound image data for analysis.
The method may further comprise the step of generating digital image having a predefined brightness and/or colour scale based on which the compound values for each sensing element are represented.
The first spectral range may correspond to a spectral range associated with red light. The second spectral range may correspond to a spectral range associated with green light.
The method may further comprise the step of illuminating the target region of tissue using a light source which provides illuminating light having first spectral range and the second spectral range. The illuminating light may have a spectral range which encompasses the first spectral range and the second spectral range. The light source may comprise at least one light emitting diode.
Certain embodiments of the present disclosure allow for images to be obtained of a target region of tissue that provide an indication of the amount and/or distribution and/or concentration of blood within the skin tissue. Certain embodiments of the present disclosure allow for images to be obtained using digital imaging sensors.
Certain embodiments of the present disclosure allow for images to be obtained using digital imaging sensors configured to produce image data having at least two components associated with different spectral ranges.
Certain embodiments of the present disclosure allow for images to be generated by combining image data having at least two components associated with different spectra ranges.
According to some embodiments, there is provided apparatus for imaging blood within a target region of tissue, comprising: an imaging device configured to output image data associated with light received by the imaging device having a first spectral range and configured to output image data associated with light received by the imaging device having a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; and a controller or controlling element configured to capture the image data associated with light received by the imaging device having the first spectral range and image data associated with light received by the imaging device having the second spectral range contemporaneously and to process the captured image data associated with light having the first spectral range and the captured image data associated with light having the second spectral range to generate compound image data associated with an amount of blood within the target region of tissue, wherein the first spectral range corresponds to a spectral range associated with red light.
According to some embodiments, there is provided apparatus for imaging blood within a target region of tissue, comprising: a light source configured to provide illuminating light having a first spectral range and to provide illuminating light having a second spectral range; an imaging device configured to output image data associated with light received by the imaging device having the first spectral range and configured to output image data associated with light received by the imaging device having the second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; and a controller or controlling element configured to capture the image data associated with light received by the imaging device having the first spectral range and image data associated with light received by the imaging device having the second spectral range contemporaneously and to process the captured image data associated with light having the first spectral range and the captured image data associated with light having the second spectral range to generate compound image data associated with an amount of blood within the target region of tissue.
According to some embodiments, there is provided a method of imaging blood within a target region of tissue comprising the steps of: capturing image data associated with at least a portion of a target region of tissue at a first spectral range; capturing image data associated with at least the portion of a target region of tissue at a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range, wherein the image data associated with at least a portion of a target region of tissue at a first spectral range and the image data associated with at least the portion of a target region of tissue at a second spectral range are captured contemporaneously; and processing the image data captured at the first spectral range and the image data captured at the second spectral range to generate compound image data associated with an amount of blood within the target tissue, wherein the second spectral range corresponds to a spectral range associated with green light.
According to some embodiments, there is provided a method of imaging blood within a target region of tissue comprising the steps of: illuminating a target region of tissue using a light source which provides illuminating light having a first spectral range and a second spectral range, wherein the illuminating light has a spectral range which encompasses the first spectral range and the second spectral range; capturing image data associated with at least a portion of a target region of tissue at the first spectral range; capturing image data associated with at least the portion of a target region of tissue at the second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range, wherein the image data associated with at least a portion of a target region of tissue at a first spectral range and the image data associated with at least the portion of a target region of tissue at a second spectral range are captured contemporaneously; and processing the image data captured at the first spectral range and the image data captured at the second spectral range to generate compound image data associated with an amount of blood within the target tissue.
According to some embodiments, there is provided apparatus for imaging blood within a target region of tissue, comprising: a light source configured to illuminate at least a portion of a target region of tissue with linearly polarised light having at least a first spectral range and a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; an imaging system having an imaging sensor configured to capture an image of at least a portion of the target region of tissue illuminated by the linearly polarised light; and a first linearly polarising filter arranged in front of the imaging device such that, in use, the polarising filter is disposed between the imaging device and the target region of tissue, wherein the first linearly polarising filter is arranged to block polarised illuminating light reflected by the target region of tissue.
The first linearly polarising filter may be arranged to polarise light in a plane which is orthogonal to the plane of polarisation of the illuminating light.
The light source may comprise a light emitter configured to emit unpolarised light and a second linearly polarising filter disposed in front of the light emitter. The light emitter may comprise at least one light emitting diode.
The second linearly polarising filter may be arranged in a cross-polarised configuration with respect to the first polarising filter such that light polarised by the second linearly polarising filter which remains polarised after being reflected by the target region of skin tissue is blocked by the first linearly polarising filter.
The first and second linearly polarising filters may be arranged such that the plane of polarisation of the first linearly polarising filter is at an angle of 90 degrees to the plane of polarisation of the second linearly polarising filter. The light source may be configured to illuminate the portion of the target region of tissue with visible light.
The first spectral range may correspond to a spectral range associated with red light and the second spectral range corresponds to a spectral range associated with green light.
The light source may comprise a diffuser arranged to provide diffused illuminating light.
The apparatus may be a smartphone.
According to some embodiments, there is provided a method of imaging blood within a target region of tissue, comprising the steps: illuminating a target region of tissue using linearly polarised light having at least a first spectral range and a second spectral range, such that the linearly polarised light is scattered and/or reflected by the target region of tissue, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; arranging an imaging system comprising an imaging sensor such that the imaging sensor is arranged to receive light scattered and/or reflected by the target region of tissue; disposing a linearly polarising filter between the target region of tissue and the imaging sensor such that scattered light which has been depolarised by the target region of tissue is transmitted by the linearly polarising filter and reflected light which remains polarised is blocked by the linearly polarising filter; and using the imaging system to capture at least one image of at least a portion of the target region of tissue using light which has been transmitted by the linearly polarising filter.
The linearly polarising filter may be arranged such that the plane of polarisation of the linearly polarising filter is orthogonal to the plane of polarisation of the illuminating light.
The step of illuminating a target region of tissue using linearly polarised light may comprise the step of using a light emitter configured to emit unpolarised light to emit light and disposing a second linearly polarising filter in front of the emitter to polarise the illuminating light. The target region of tissue may be illuminated with visible light.
The visible light may comprise a first spectral range that corresponds to a spectral range associated with red light and a second spectral range that corresponds to a spectral range associated with green light. The linearly polarised light may be diffused light.
According to some embodiments, there is provided a method of imaging blood within a target region of tissue, comprising the steps: illuminating a target region of tissue using linearly polarised light having at least a first spectral range and a second spectral range, such that the linearly polarised light is scattered and/or reflected by the target region of tissue, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; transmitting by a linearly polarising filter disposed between the target region of tissue and the imaging sensor scattered light which has been depolarised by the target region of tissue and blocking by the linearly polarising filter reflected light which remains polarised; receiving with an imaging sensor light scattered and/or reflected by the target region of tissue; and capturing at least one image of at least a portion of the target region of tissue using light which has been transmitted by the linearly polarising filter.
The linearly polarising filter may be arranged such that the plane of polarisation of the linearly polarising filter is orthogonal to the plane of polarisation of the illuminating light.
The step of illuminating a target region of tissue using linearly polarised light may comprise the step of using a light emitter configured to emit unpolarised light to emit light and disposing a second linearly polarising filter in front of the emitter to polarise the illuminating light. The target region of tissue may be illuminated with visible light.
The visible light may comprise a first spectral range that corresponds to a spectral range associated with red light and a second spectral range that corresponds to a spectral range associated with green light. The linearly polarised light may be diffused light.
Certain embodiments of the present disclosure allow for images of blood within tissue to be obtained that are not adversely affected by light which is reflected by the tissue without penetrating the tissue.
Embodiments of the present disclosure will now be described, by way of example only, with reference to the accompanying drawings in which:
The apparatus 2 comprises a support structure in the form of a support frame 4 having a base 6 on which the hand 7 is placed, walls 8, 10 which extend upwardly from the base 6 and an equipment support platform 12. The support platform 12 extends horizontally from one wall 8 to the other wall 10 and is located above the base 6 and spaced away from the base 6 by a suitable distance. In the embodiment shown, the support platform 12 is spaced from the base 6 by 30 cm. The support platform 12 may be spaced from the base 6 by between 5 cm and 100 cm, such as between 20 cm and 50 cm in accordance with requirements such as a requirement to keep a target region of tissue within a focal range of a camera module, as described below.
A light source 14 is secured to the support platform 12 and arranged to illuminate the back of the hand 7 placed on the base 6 below. A camera module 16 is also secured to the support platform 12 and arranged to capture images of the back of the hand 7 placed on the base 6 below. The support frame 4 therefore holds the light source 14 and the camera module 16 in a fixed special relationship with respect to each other and the base 6. A display unit 18 for processing and displaying images captured by the camera module 16 is secured to the support platform 12. In the embodiment show, the display unit 18 comprises a portable device having an integrated screen 20. The display unit 18 may be a tablet device, smart phone, laptop, computer or the like.
In the embodiment shown, the light source 14 is a high-intensity light source in the form of an LED torch. The LED torch comprises a plurality of LEDs 15 which are configured to emit white light having a broad spectral range. For example, each LED may be configured to emit light having spectral range of wavelengths between 380 nm and 770 nm.
The camera module 16 comprises a digital imaging sensor 17 having a two-dimensional array of discrete sensing elements. Each sensing element is configured to produce an output having three separate components including: a component associated with the amount of red light received at the sensing element; a component associated with the amount of green light received at the sensing element; and a component associated with the amount of blue light received at the sensing element.
In the embodiment shown, each sensing element comprises three separate identical sensors. Each sensing element has a respective filter configured to transmit light within a predefined spectral range associated with one of red, green and blue light respectively.
Such digital imaging sensors are commonly used in the field of digital photography. In the embodiment shown, the digital imaging sensor is a complementary metal-oxide semiconductor (CMOS) digital imaging sensor. The sensor is a Sony™ IMX219 sensor configured to produce image data for generating a 3296 by 2512 pixel image.
The spectral response curves for each of the component outputs of the digital imaging sensor 17 is shown in
The spectral response curve associated with the amount of blue light received at each sensing element is shown by response curve B. The response curve has a peak response for blue light within the spectral range 400 nm and 500 nm. The spectral response curve associated with the amount of green light received at each sensing element is shown by response curve G. The response curve has a peak response for green light within the spectral range 520 nm and 580 nm. The spectral response curve associated with the amount of red light received at the sensing element is shown by response curve R. The response curve has a peak response for red light within the spectral range 590 nm and 750 nm.
The imaging sensor 17 is therefore configured to produce output components associated with the amount of blue, green and red light received at each sensing element which can be processed to generate an image comprising an array of pixels in which each pixel is associated with a respective sensor element. Images can therefore be produced in which each pixel has a blue, green or red value that corresponds to the amount of blue, green and red light received at each sensing element. Other sensors having suitable response curves such as a charge coupled devices (CCD) or the like could of course be utilised.
A flow chart illustrating a method of imaging blood within a target region of tissue in order to determine the distribution of blood within the tissue is shown in
At step S1010, a hand 7 is placed with the palm facing upward on the base 6 of the support frame 4 below the light source 14 and the camera module 16.
At step S1020, the light source 14 is activated by the processor 24 to illuminate the region of the hand 7 in view of the camera module 16. While the hand is illuminated, the camera module 16 is controlled by the processor 24 to produce image data associated with a target region of tissue of the hand 7 which is within view of the camera module 16 and illuminated by the light source 14. In particular, the digital imaging sensor 17 of the camera module 16 is controlled to produce image data for each of the sensing elements forming the array of sensing elements. The image data for each sensing element has blue, green and red components, as described above.
At step S1030, the processor 24 determines a value for each of the blue, green and red components based on the received image data. In particular, the processor 24 generates a red value IR and a green value IG and a blue value IB for each sensing element. The red value IR is associated with the amount of red light received by the sensing element. The green value IG is associated with the amount of green light received by the same sensing element. The blue value IB is associated with the amount of blue light received by the same sensing element. The values are then used to generate a visual digital image and a compound digital image of the target region of tissue. The step of generating a visual digital image is optional. Each image comprises an array of pixels in which the location of each pixel corresponds to the location of a corresponding sensing element of the imaging sensor 17.
The processor 24 generates the visual digital image, as shown in
In order to generate the compound digital image, the processor 24 generates a compound value IC for each sensing element which corresponds to a respective pixel of the compound digital image.
A compound value IC for each pixel is generated by subtracting the green value IG from the red value IR. In order to compensate for differences in the amount of red and green light that is emitted by the light source 14, or to compensate for differences in the sensitivity of the imaging sensor 17 to red and green light, a scaling factor ‘a’ is applied to the green value IG. The value of ‘a’ may also set in accordance with other subjective factors related to representation and interpretation of the second image. The value of ‘a’ may be in the range 0.01 to 100, such as in the range 0.1 to 10 and may be in the range 1 to 5, such as 1. The compound value IC is therefore calculated as follows:
IC=IR−a·IG
The magnitude of the compound value IC provides an indication of the local distribution of blood within the target region of tissue associated with the pixel. This is because haemoglobin within blood absorbs green light much better than red light and so the amount of green light received at a sensing element is heavily dependent on the amount of blood within skin tissue whereas the amount of red light received at a sensing element is not.
To aid further explanation,
Compared against the spectral response curves shown in
The approximate ranges of the response curves G and R are superimposed on
The green value IG for each pixel is proportional to the amount of green light detected by the imaging sensor 17 and so is inversely proportional to the amount of light absorbed. Therefore, a low green value IG, and by implication a high compound value IC, is associated with a large amount of blood within the region of tissue. The compound value IC therefore provides a reliable indicator of the amount of blood within tissue depicted by an associated pixel in the compound image.
In contrast, the skin tissue itself absorbs green and red light having spectral ranges corresponding to those shown in
In the embodiment shown, the compound value IC is converted for each pixel using a suitable scale, for example, based on brightness and/or a colour range to produce the second image, as shown in
Although spectral ranges associated with high and low amounts of absorptivity by haemoglobin and oxygenated haemoglobin are utilised in the present embodiment to evaluate the concentration of blood within tissue, other spectral ranges could be selected in addition to, or as an alternative, that correspond to high and low amounts of absorptivity for other compounds that may be found within tissue and other compounds that may be found within blood.
It will be appreciated that, in the present embodiment, the light source 14 is configured to emit light having at least one wavelength, or range of wavelengths, which is both well absorbed by blood and which falls within the range of the response curve of the imaging sensor 17 associated with green light and at least one wavelength, or range of wavelengths, which is less well absorbed by blood and which falls within the range of the response curve of the imaging sensor 17 associated with red light.
At step S2010, a hand is placed on the base 6 of the apparatus 2. At step S2020, the light source 14 is activated to illuminate a target region of tissue of the hand. At step 2030, a first compound image is generated using components of the output of the camera module 16 as described above in connection with the process step S1030. A visual image may also be generated, as described in step S1030. However, such a step is optional and omitted in this instance. At step S2040, a first compound image is stored, transmitted or displayed on the integrated display unit 18.
At step 2050, the inflatable cuff is inflated in order to restrict blood flow to the target region of tissue. After a suitable period of time has elapsed in which it can be expected that the restriction has reduced blood flow within the target region of tissue, the target region is illuminated again at step S2060, image data is captured by the camera module 16 and a second compound image is generated at step S2070. The suitable period of time may be at least 1 second or at least 2 seconds or at least 5 seconds. The light source 14 may be deactivated between capture of the first and second compound images or else remain activated throughout steps S2020 to S2060.
Comparison of first and second compound images, for example by a clinician, enables a qualitative assessment of blood perfusion to the target region of tissue. For example, if the inflation pressure of the cuff is known, the amount of blood perfusion in the second compound image in comparison the first compound image may be used to determine whether blood flow to the tissue is within normal bounds.
In further embodiments, restriction of blood flow to the target region of tissue may be done by a tourniquet or pressing against a vessel supplying blood to the tissue or by pressing against the target region of tissue itself.
At steps S3010 to S3050, which are the same as steps S2010 to S2050, a first compound image of a target region of tissue is obtained. An example of a first compound image is shown in
At step S3060, the target region of tissue is illuminated and image data is captured such that at step S3070, at least two consecutive compound images of the target region of tissue are captured after the cuff has been inflated. The consecutive images are stored, displayed or transmitted at step S3080 for analysis. At step S3090, the consecutive images are compared to determine whether the flow of blood within the target region has stabilised. The consecutive images may be compared visually by a clinician or automatically using image analysis software. If blood flow has not stabilised, steps S3060 to S3090 are repeated until it is determined that flow of blood within the target region of tissue is stable. An example of a compound image of the target region of tissue after it has been determined that the flow of blood within the tissue has stabilise is shown in
At step S3100, the time t1 at which blood flow has stabilised is recorded and the restriction removed immediately at step S3110 by deflation of the cuff. Steps S3120 to S3140 (which correspond to steps S3020 to S3040) are then followed to obtain a further compound image of the target region of tissue. At step S3150, the further compound image is compared against the first compound image to determine whether the distribution of blood within the tissue at the target region, and hence the flow of blood within the tissue, has returned/recovered to the original state prior to restriction of the blood flow. The comparison may once again be made visually by a clinician or automatically using suitable image analysis software. If distribution of blood has not returned to the original state, steps S3120 to S3150 are repeated. Once it is determined that the distribution of blood has returned, or has substantially returned, to its original state, the time t2 at which it does so is recorded. An example of a compound image obtained showing the distribution of blood within the target region of tissue once it has returned to its original state is shown in
It will be appreciated that small movements of the tissue, hysteresis within the tissue and other variations will make it unlikely that blood flow within the tissue will return to the original state exactly. Therefore, suitable parameters may be used such as a proportion of the pixels of the compound image having a compound value IC which is within a predetermined percentage of the first compound image or a return to an average IC value for a selection of pixels of the image may be sufficient to determine that the distribution of blood has returned to the original state. The difference between time t2 and time t1 can then be calculated to determine a recovery time tR that provides an indication of the quality of blood perfusion at the target region.
A variant of the method shown in
The first and second linear polarising filters are 28, 30 are arranged in a cross-polarised configuration so that light polarised by the second linear polarising filter 30 which has not been de-polarised before reaching the first linear polarising filter 28 will be blocked by the first linear polarising filter 28 and so prevented from reaching the imaging sensor 17 in the camera module 16. The polarising plane of the first linear polarising filter 28 is at 90 degrees to the polarising plane of the second linear polarising filter 30. The first and second linear polarising filters 28, 30 are set up in a cross-polarised configuration by placing a piece of flat aluminium foil (not shown) on the base 6 in the region at which the hand 7 is placed. The light source 14 is then used to illuminate the aluminium foil and images are captured of the illuminated portion of the aluminium foil. The first linear polarising filter 28 is then rotated with respect to the second linear polarising filter 30 until the light intensity of the captured images is at a minimum. At this orientation, the two polarising filters 28, 30 are considered to be in a cross-polarised configuration.
Only light T transmitted by the light source 14 and polarised by the second polarising filter 30 which is subsequently depolarised by the target region of tissue, for example on account of scattering events within the tissue, passes through the first linear polarising filter 28 to the camera module 16. Consequently, only light RS which has penetrated the epidermis 7a of the skin tissue which undergoes multiple scattering events, and so has had an increased likelihood of being absorbed by blood vessels within the skin tissue, is used to generate an image of the target region. Light R which has been reflected without penetrating the skin tissue, and so which would provide an unreliable indication of the amount of blood within the skin tissue is prevented from reaching the camera module 16. The embodiment, when used to capture images using the methods outlined above, improves the quality and reliability of the images generated.
In some embodiments, a dedicated light source may be unnecessary since ambient light may be sufficient.
Camera modules comprising CCD or CMOS imaging sensors have been described with respect to the embodiments above. Other imaging sensors may be used that are suitable for detecting the spectral content of light and producing a digital image comprising a plurality of pixels in which each pixel can have a value that corresponds a spectral content of light received by the sensor at a corresponding portion of the sensor. Other imaging sensors having other suitable response curves may also be used.
Image data or images generated using image data can be processed or post-processed to enhance features of interest. For example, the brightness of images can be adjusted or contrast enhanced or colour adjusted or noise filter techniques or the like can be applied. Other imaging processing techniques may be used to highlight features of interest within the images.
Various light sources can be used for illumination. Light emitting diodes or a single diode may be used in accordance with the embodiments described above. Surface mounted diodes, which are compact, widely available, inexpensive, reliable, produce high-intensity light, have lower power consumption and are easy to integrate, may be used. Other light sources such as lasers, laser diodes, digital light projectors (DLPs), organic light emitting diodes (OLED) or incandescent light sources or the like may be used. The light source may be a broad-band or white light source such as the light source used in the embodiments described above, but may be a light source capable of illuminating the target region at two or more wavelengths, such as two monochromatic light sources, two laser diodes of different wavelengths, a multi-coloured LED or the like. Two light sources may be used, neither of which has an emission spectra extending over a region of overlap of response curves for the imaging sensor in which there is a significant response for each response curve. In an arrangement which comprises two light sources, the spectral range of one light source may be different from the spectral range of the other light source. For example, red and green LEDs could be used as respective light sources. An imaging sensor could be used which does not discriminate between the two spectral ranges and the light sources may be sequentially pulsed (i.e. activated and deactivated alternately) in order to obtain images at each of the respective spectral ranges. Diffuser of lens arrangements may be used to provide a reasonably uniform illumination across a region of interest or to focus light on particular areas of interest.
The light source, camera module and display unit may be incorporated into a portable hand-held device having a single housing in which the components are housed. For example, a hand-held digital camera unit having an integrated flash unit could be configured to generate images in accordance with the imaging methods described above.
In some embodiments, the portable hand-held device can be a smartphone, tablet, or the like with an integrated camera and a flash. For example, as illustrated in
One or more polarising filters (as described herein) can be positioned over the flash. The flash can be turned on for the duration of the image or video capture. An orthogonal polarising filter (whose polarising plane can be at 90 degrees to polarising plane(s) of the one or more filters positioned over the flash as described herein) can be positioned over an image lens of the camera. In some cases, the one or more filters positioned over the flash and the orthogonal filter positioned over the image lens are connected to be in cross-polarised configuration as described herein. The one or more filters positioned over the flash can be tinted to prioritise only the frequencies of interest as described herein.
Alternatively or additionally, a lens, such as macro lens 1210, can be used over the image lens of the camera. Alternatively or additionally, a separate illumination source can be used. In any of the embodiments described herein, Eulerian amplification techniques can be used in the analysis, as described in U.S. Provisional Patent Application Nos. 62/506,524, filed May 15, 2017 and 62/506,551, filed May 15, 2017, each of which is incorporated herein by reference in its entirety. Eulerian magnification can, for example, amplify variations in absorption due to the pulse providing bursts of blood.
It will be appreciated that throughout this specification reference is made to a wound. It is to be understood that the term wound is to be broadly construed and encompasses open and closed wounds in which skin is torn, cut or punctured or where trauma causes a contusion, or any other superficial or other conditions or imperfections on the skin of a patient or otherwise that benefit from reduced pressure treatment. A wound is thus broadly defined as any damaged region of tissue where fluid may or may not be produced. Examples of such wounds include, but are not limited to, abdominal wounds or other large or incisional wounds, either as a result of surgery, trauma, sterniotomies, fasciotomies, or other conditions, dehisced wounds, acute wounds, chronic wounds, subacute and dehisced wounds, traumatic wounds, flaps and skin grafts, lacerations, abrasions, contusions, burns, diabetic ulcers, pressure ulcers, stoma, surgical wounds, trauma and venous ulcers or the like.
In the drawings like reference numerals refer to like parts.
Throughout the description and claims of this specification, the words “comprise” and “contain” and variations of them mean “including but not limited to” and they are not intended to (and do not) exclude other moieties, additives, components, integers or steps. Throughout the description and claims of this specification, the singular encompasses the plural unless the context otherwise requires. In particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise.
Features, integers, characteristics or groups described in conjunction with a particular aspect, embodiment or example of the disclosure are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of the features and/or steps are mutually exclusive. The disclosure is not restricted to any details of any foregoing embodiments. The disclosure extends to any novel one, or novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
The reader's attention is directed to all papers and documents which are filed concurrently with or previous to this specification in connection with this application and which are open to public inspection with this specification, and the contents of all such papers and documents are incorporated herein by reference in their entireties.
Number | Date | Country | Kind |
---|---|---|---|
1703771 | Mar 2017 | GB | national |
1703772 | Mar 2017 | GB | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2018/055945 | 3/9/2018 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2018/162732 | 9/13/2018 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3896802 | Wiliams | Jul 1975 | A |
4334530 | Hassell | Jun 1982 | A |
5090410 | Saper et al. | Feb 1992 | A |
5253654 | Thomas et al. | Oct 1993 | A |
5635201 | Fabo | Jun 1997 | A |
5642096 | Leyerer et al. | Jun 1997 | A |
5678448 | Fallen et al. | Oct 1997 | A |
5690610 | Ito et al. | Nov 1997 | A |
5836990 | Li | Nov 1998 | A |
6095992 | Augustine | Aug 2000 | A |
6178342 | Borgos et al. | Jan 2001 | B1 |
6381482 | Jayaraman et al. | Apr 2002 | B1 |
6517484 | Wilk et al. | Feb 2003 | B1 |
6551252 | Sackner et al. | Apr 2003 | B2 |
6731987 | McAdams et al. | May 2004 | B1 |
7077832 | Fleischmann | Jul 2006 | B2 |
7088591 | Kishimoto et al. | Aug 2006 | B2 |
7201063 | Taylor et al. | Apr 2007 | B2 |
7206623 | Blank et al. | Apr 2007 | B2 |
7289205 | Yaroslavsky et al. | Oct 2007 | B2 |
7316652 | Dalgaard et al. | Jan 2008 | B2 |
7429255 | Thompson | Sep 2008 | B2 |
7520875 | Bernabei | Apr 2009 | B2 |
7521292 | Rogers et al. | Apr 2009 | B2 |
7569742 | Haggstrom et al. | Aug 2009 | B2 |
7625117 | Haslett et al. | Dec 2009 | B2 |
7687678 | Jacobs | Mar 2010 | B2 |
7838717 | Haggstrom et al. | Nov 2010 | B2 |
7846141 | Weston | Dec 2010 | B2 |
7877866 | Greenberg et al. | Feb 2011 | B1 |
7884258 | Boehringer et al. | Feb 2011 | B2 |
7904133 | Gehman et al. | Mar 2011 | B2 |
7922676 | Daskal et al. | Apr 2011 | B2 |
7942869 | Houbolt et al. | May 2011 | B2 |
7945302 | McAdams | May 2011 | B2 |
8019401 | Smith et al. | Sep 2011 | B1 |
8032210 | Finneran et al. | Oct 2011 | B2 |
8060174 | Simpson et al. | Nov 2011 | B2 |
8079247 | Russell et al. | Dec 2011 | B2 |
8111165 | Ortega et al. | Feb 2012 | B2 |
8116841 | Bly et al. | Feb 2012 | B2 |
8182425 | Stamatas et al. | May 2012 | B2 |
8207392 | Haggstrom et al. | Jun 2012 | B2 |
8238996 | Burnes | Aug 2012 | B2 |
8241231 | Bausewein et al. | Aug 2012 | B2 |
8332053 | Patterson et al. | Dec 2012 | B1 |
8333874 | Currie et al. | Dec 2012 | B2 |
8366692 | Weston | Feb 2013 | B2 |
8480641 | Jacobs | Jul 2013 | B2 |
8579872 | Coulthard et al. | Nov 2013 | B2 |
8644911 | Panasyuk et al. | Feb 2014 | B1 |
8663106 | Stivoric et al. | Mar 2014 | B2 |
8682442 | McAdams | Mar 2014 | B2 |
8783948 | Panda et al. | Jul 2014 | B2 |
8788009 | Greene et al. | Jul 2014 | B2 |
8800386 | Taylor | Aug 2014 | B2 |
8818478 | Scheffler et al. | Aug 2014 | B2 |
8829263 | Haggstrom et al. | Sep 2014 | B2 |
8848187 | Uematsu et al. | Sep 2014 | B2 |
8894590 | Lamoise et al. | Nov 2014 | B2 |
8925392 | Esposito et al. | Jan 2015 | B2 |
8934957 | Dias et al. | Jan 2015 | B2 |
8934965 | Rogers et al. | Jan 2015 | B2 |
8943897 | Beauvais et al. | Feb 2015 | B2 |
8948839 | Longinotti-Buitoni et al. | Feb 2015 | B1 |
8974428 | Shuler et al. | Mar 2015 | B2 |
8997588 | Taylor | Apr 2015 | B2 |
9000251 | Murphy et al. | Apr 2015 | B2 |
9042075 | Borini et al. | May 2015 | B2 |
9192531 | Wu | Nov 2015 | B2 |
9192700 | Weston et al. | Nov 2015 | B2 |
9204806 | Stivoric et al. | Dec 2015 | B2 |
9220455 | Sarrafzadeh et al. | Dec 2015 | B2 |
9226402 | Hsu | Dec 2015 | B2 |
9282897 | Ross, Jr. et al. | Mar 2016 | B2 |
9314175 | Jacofsky et al. | Apr 2016 | B2 |
9320473 | Shuler | Apr 2016 | B2 |
9372123 | Li et al. | Jun 2016 | B2 |
9378450 | Mei et al. | Jun 2016 | B1 |
9386947 | Johnson | Jul 2016 | B2 |
9393354 | Freedman et al. | Jul 2016 | B2 |
9402988 | Buchanan et al. | Aug 2016 | B2 |
9408573 | Welch et al. | Aug 2016 | B2 |
9427179 | Mestrovic et al. | Aug 2016 | B2 |
9439599 | Thompson et al. | Sep 2016 | B2 |
9483726 | Mei et al. | Nov 2016 | B2 |
9494474 | Servati et al. | Nov 2016 | B2 |
9511215 | Skiba | Dec 2016 | B2 |
9516758 | Arora et al. | Dec 2016 | B2 |
9526439 | Connelly et al. | Dec 2016 | B2 |
9554484 | Rogers et al. | Jan 2017 | B2 |
9572507 | Moore et al. | Feb 2017 | B2 |
9582072 | Connor | Feb 2017 | B2 |
9585620 | Paquet et al. | Mar 2017 | B2 |
9587991 | Padiy | Mar 2017 | B2 |
9592007 | Nuovo et al. | Mar 2017 | B2 |
9603560 | Monty et al. | Mar 2017 | B2 |
9610388 | Aceto et al. | Apr 2017 | B2 |
9613911 | Rogers et al. | Apr 2017 | B2 |
9629584 | Barber et al. | Apr 2017 | B2 |
9675238 | Iida et al. | Jun 2017 | B2 |
9687195 | Sims et al. | Jun 2017 | B2 |
9717565 | Blair | Aug 2017 | B2 |
9829471 | Hammond et al. | Nov 2017 | B2 |
9907103 | Chen et al. | Feb 2018 | B2 |
9999711 | Weston et al. | Jun 2018 | B2 |
10004643 | Luckemeyer et al. | Jun 2018 | B2 |
10046096 | Askem et al. | Aug 2018 | B2 |
10080524 | Xi | Sep 2018 | B1 |
10086117 | Locke et al. | Oct 2018 | B2 |
10117705 | Chernov et al. | Nov 2018 | B2 |
10152789 | Carnes et al. | Dec 2018 | B2 |
10182740 | Tonar et al. | Jan 2019 | B2 |
10201644 | Haggstrom et al. | Feb 2019 | B2 |
10207031 | Toth | Feb 2019 | B2 |
10209213 | Kang et al. | Feb 2019 | B2 |
10285620 | Jung et al. | May 2019 | B2 |
10288590 | Hammond et al. | May 2019 | B2 |
10321862 | Dalene et al. | Jun 2019 | B2 |
10463773 | Haggstrom et al. | Nov 2019 | B2 |
10857038 | Zamierowski et al. | Dec 2020 | B2 |
11026847 | Piotrowski et al. | Jun 2021 | B2 |
20020016536 | Benni | Feb 2002 | A1 |
20020135752 | Sokolov et al. | Sep 2002 | A1 |
20030033032 | Lind et al. | Feb 2003 | A1 |
20030036751 | Anderson | Feb 2003 | A1 |
20030208148 | Sullivan | Nov 2003 | A1 |
20030210810 | Gee, Jr. et al. | Nov 2003 | A1 |
20030216630 | Jersey-Willuhn et al. | Nov 2003 | A1 |
20040034293 | Kimball | Feb 2004 | A1 |
20040230132 | Shehada | Nov 2004 | A1 |
20050088832 | Su et al. | Apr 2005 | A1 |
20050240107 | Alfano et al. | Oct 2005 | A1 |
20050280531 | Fadem et al. | Dec 2005 | A1 |
20050281445 | Marcotte | Dec 2005 | A1 |
20060052678 | Drinan et al. | Mar 2006 | A1 |
20060058690 | Bartnik et al. | Mar 2006 | A1 |
20060181791 | Van Beek et al. | Aug 2006 | A1 |
20060234383 | Gough | Oct 2006 | A1 |
20060241495 | Kurtz | Oct 2006 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070173892 | Fleischer et al. | Jul 2007 | A1 |
20070191754 | Aali | Aug 2007 | A1 |
20070260421 | Berner, Jr. et al. | Nov 2007 | A1 |
20070293748 | Engvall et al. | Dec 2007 | A1 |
20080081973 | Hoarau | Apr 2008 | A1 |
20080167535 | Stivoric et al. | Jul 2008 | A1 |
20080258717 | Igney et al. | Oct 2008 | A1 |
20080287747 | Mestrovic et al. | Nov 2008 | A1 |
20080319282 | Tran | Dec 2008 | A1 |
20080319283 | Cotton et al. | Dec 2008 | A1 |
20090149800 | Durand | Jun 2009 | A1 |
20090177051 | Arons et al. | Jul 2009 | A1 |
20090177110 | Lyden et al. | Jul 2009 | A1 |
20090209830 | Nagle et al. | Aug 2009 | A1 |
20090234206 | Gaspard et al. | Sep 2009 | A1 |
20090245601 | Cohen et al. | Oct 2009 | A1 |
20100022990 | Karpowicz et al. | Jan 2010 | A1 |
20100025831 | Yamazaki et al. | Feb 2010 | A1 |
20100166252 | Ahmed et al. | Jul 2010 | A1 |
20100168727 | Hancock et al. | Jul 2010 | A1 |
20100268111 | Drinan et al. | Oct 2010 | A1 |
20100305473 | Yuzhakov | Dec 2010 | A1 |
20110004088 | Grossman | Jan 2011 | A1 |
20110015591 | Hanson et al. | Jan 2011 | A1 |
20110054283 | Shuler | Mar 2011 | A1 |
20110092958 | Jacobs | Apr 2011 | A1 |
20110130697 | Nagle et al. | Jun 2011 | A1 |
20110140703 | Chiao et al. | Jun 2011 | A1 |
20110190639 | Peltie et al. | Aug 2011 | A1 |
20110218757 | Callsen et al. | Sep 2011 | A1 |
20110242532 | McKenna | Oct 2011 | A1 |
20110245682 | Robinson et al. | Oct 2011 | A1 |
20110301441 | Bandic et al. | Dec 2011 | A1 |
20120029306 | Paquet et al. | Feb 2012 | A1 |
20120029307 | Paquet et al. | Feb 2012 | A1 |
20120029410 | Koenig et al. | Feb 2012 | A1 |
20120112347 | Eckhardt et al. | May 2012 | A1 |
20120165717 | Al Khaburi et al. | Jun 2012 | A1 |
20120166680 | Masoud | Jun 2012 | A1 |
20120190956 | Connolly | Jul 2012 | A1 |
20120190989 | Kaiser et al. | Jul 2012 | A1 |
20120265120 | Beisang, III et al. | Oct 2012 | A1 |
20120271265 | Langdon | Oct 2012 | A1 |
20120277559 | Kohl-Bareis et al. | Nov 2012 | A1 |
20120316538 | Heiser et al. | Dec 2012 | A1 |
20120330252 | Stokes et al. | Dec 2012 | A1 |
20130041235 | Rogers et al. | Feb 2013 | A1 |
20130064772 | Swiss et al. | Mar 2013 | A1 |
20130121544 | Sarrafzadeh et al. | May 2013 | A1 |
20130123722 | Pratt et al. | May 2013 | A1 |
20130151223 | Zamierowski et al. | Jun 2013 | A1 |
20130200268 | Rafferty et al. | Aug 2013 | A1 |
20130261409 | Pathak et al. | Oct 2013 | A1 |
20130271278 | Duesterhof et al. | Oct 2013 | A1 |
20130274629 | Duesterhoft et al. | Oct 2013 | A1 |
20130317367 | Shuler | Nov 2013 | A1 |
20140012108 | McPeak | Jan 2014 | A1 |
20140018637 | Bennett et al. | Jan 2014 | A1 |
20140024905 | Sarrafzadeh et al. | Jan 2014 | A1 |
20140031663 | Gallego et al. | Jan 2014 | A1 |
20140072190 | Wu et al. | Mar 2014 | A1 |
20140075658 | McGuin | Mar 2014 | A1 |
20140107495 | Marinelli et al. | Apr 2014 | A1 |
20140107498 | Bower et al. | Apr 2014 | A1 |
20140147611 | Ackerman, Jr. et al. | May 2014 | A1 |
20140203797 | Stivoric et al. | Jul 2014 | A1 |
20140206947 | Isserow et al. | Jul 2014 | A1 |
20140232516 | Stivoric et al. | Aug 2014 | A1 |
20140235166 | Molettiere et al. | Aug 2014 | A1 |
20140243709 | Gibson et al. | Aug 2014 | A1 |
20140296749 | Reid, Jr. et al. | Oct 2014 | A1 |
20140298927 | Allin et al. | Oct 2014 | A1 |
20140298928 | Duesterhoft et al. | Oct 2014 | A1 |
20140303463 | Robinson et al. | Oct 2014 | A1 |
20140324120 | Bogie et al. | Oct 2014 | A1 |
20140340857 | Hsu et al. | Nov 2014 | A1 |
20140343478 | Brennan et al. | Nov 2014 | A1 |
20140350882 | Everett et al. | Nov 2014 | A1 |
20150018792 | Marsiquet et al. | Jan 2015 | A1 |
20150025343 | Gareau et al. | Jan 2015 | A1 |
20150138330 | Krishnamoorthi | May 2015 | A1 |
20150141767 | Rogers et al. | May 2015 | A1 |
20150148760 | Dodd et al. | May 2015 | A1 |
20150150479 | Yoshino et al. | Jun 2015 | A1 |
20150182166 | Evans et al. | Jul 2015 | A1 |
20150223716 | Korkala et al. | Aug 2015 | A1 |
20150257644 | Cao | Sep 2015 | A1 |
20150265191 | Harding et al. | Sep 2015 | A1 |
20150292968 | Vogt et al. | Oct 2015 | A1 |
20150313476 | Pisani et al. | Nov 2015 | A1 |
20150313533 | Rapp et al. | Nov 2015 | A1 |
20150327777 | Kostic et al. | Nov 2015 | A1 |
20150335254 | Fastert et al. | Nov 2015 | A1 |
20150335287 | Neuman et al. | Nov 2015 | A1 |
20150335288 | Toth et al. | Nov 2015 | A1 |
20150351970 | Dagger et al. | Dec 2015 | A1 |
20150359485 | Berg et al. | Dec 2015 | A1 |
20150374309 | Farkas et al. | Dec 2015 | A1 |
20160015962 | Shokoueinejad Maragheh | Jan 2016 | A1 |
20160022223 | Grundfest et al. | Jan 2016 | A1 |
20160029900 | LaPlante et al. | Feb 2016 | A1 |
20160030132 | Cheung et al. | Feb 2016 | A1 |
20160038045 | Shapiro | Feb 2016 | A1 |
20160038083 | Ding et al. | Feb 2016 | A1 |
20160051147 | Cohen et al. | Feb 2016 | A1 |
20160058380 | Lee et al. | Mar 2016 | A1 |
20160066854 | Mei et al. | Mar 2016 | A1 |
20160069743 | McQuilkin et al. | Mar 2016 | A1 |
20160074234 | Abichandi et al. | Mar 2016 | A1 |
20160081580 | Bergelin et al. | Mar 2016 | A1 |
20160081601 | Ballam et al. | Mar 2016 | A1 |
20160100790 | Cantu et al. | Apr 2016 | A1 |
20160100987 | Hartwell et al. | Apr 2016 | A1 |
20160101282 | Bergelin et al. | Apr 2016 | A1 |
20160129469 | Kulinsky et al. | May 2016 | A1 |
20160143534 | Hyde et al. | May 2016 | A1 |
20160157779 | Baxi et al. | Jun 2016 | A1 |
20160165719 | Li et al. | Jun 2016 | A1 |
20160166438 | Rovaniemi | Jun 2016 | A1 |
20160213269 | Lam et al. | Jul 2016 | A1 |
20160228049 | Nackaerts et al. | Aug 2016 | A1 |
20160232807 | Ghaffari et al. | Aug 2016 | A1 |
20160242331 | Park et al. | Aug 2016 | A1 |
20160249810 | Darty et al. | Sep 2016 | A1 |
20160262672 | Hammond et al. | Sep 2016 | A1 |
20160262687 | Vaidyanathan et al. | Sep 2016 | A1 |
20160270700 | Baxi et al. | Sep 2016 | A1 |
20160287177 | Huppert et al. | Oct 2016 | A1 |
20160302729 | Starr et al. | Oct 2016 | A1 |
20160310023 | Chachisvilis et al. | Oct 2016 | A1 |
20160317057 | Li et al. | Nov 2016 | A1 |
20160331263 | Cailler et al. | Nov 2016 | A1 |
20160331322 | Son et al. | Nov 2016 | A1 |
20160338591 | Lachenbruch et al. | Nov 2016 | A1 |
20160354001 | Buckley et al. | Dec 2016 | A1 |
20160367189 | Aimone et al. | Dec 2016 | A1 |
20160367192 | Iyengar et al. | Dec 2016 | A1 |
20160367406 | Barnett | Dec 2016 | A1 |
20170000407 | Saxby et al. | Jan 2017 | A1 |
20170007853 | Alford et al. | Jan 2017 | A1 |
20170027498 | Larson et al. | Feb 2017 | A1 |
20170079740 | Hufnagel et al. | Mar 2017 | A1 |
20170086519 | Vigano et al. | Mar 2017 | A1 |
20170086709 | Khine et al. | Mar 2017 | A1 |
20170095208 | Oberleitner et al. | Apr 2017 | A1 |
20170146474 | Bedell et al. | May 2017 | A1 |
20170156594 | Stivoric et al. | Jun 2017 | A1 |
20170156621 | Bettinger et al. | Jun 2017 | A1 |
20170156658 | Maharbiz et al. | Jun 2017 | A1 |
20170164865 | Rafferty et al. | Jun 2017 | A1 |
20170164876 | Hyde et al. | Jun 2017 | A1 |
20170172439 | Zhu et al. | Jun 2017 | A1 |
20170202711 | Cernasov et al. | Jul 2017 | A1 |
20170224271 | Lachenbruch et al. | Aug 2017 | A1 |
20170231015 | Jang et al. | Aug 2017 | A1 |
20170258972 | Weston | Sep 2017 | A1 |
20170304510 | Askem et al. | Oct 2017 | A1 |
20170319075 | Homan et al. | Nov 2017 | A1 |
20170326004 | Long et al. | Nov 2017 | A1 |
20170367644 | Sharman et al. | Dec 2017 | A1 |
20180008177 | Shimuta et al. | Jan 2018 | A1 |
20180055359 | Shamim et al. | Mar 2018 | A1 |
20180055697 | Mihail et al. | Mar 2018 | A1 |
20180056087 | Ribiero et al. | Mar 2018 | A1 |
20180070880 | Trembly et al. | Mar 2018 | A1 |
20180074547 | Smadi et al. | Mar 2018 | A1 |
20180116877 | Ineichen | May 2018 | A1 |
20180128681 | Otsuka | May 2018 | A1 |
20180132287 | Cheng et al. | May 2018 | A1 |
20180192514 | Seo | Jul 2018 | A1 |
20180200414 | Askem et al. | Jul 2018 | A1 |
20180206758 | Feldkamp et al. | Jul 2018 | A1 |
20180235484 | Mozdzierz | Aug 2018 | A1 |
20180296397 | Askem et al. | Oct 2018 | A1 |
20190001032 | Weston et al. | Jan 2019 | A1 |
20190021911 | Askem et al. | Jan 2019 | A1 |
20190060126 | Ribble et al. | Feb 2019 | A1 |
20190076298 | Quintanar et al. | Mar 2019 | A1 |
20190083025 | Aung et al. | Mar 2019 | A1 |
20190133812 | Seres et al. | May 2019 | A1 |
20190134280 | Toth | May 2019 | A1 |
20190159938 | Askem et al. | May 2019 | A1 |
20190175098 | Burns | Jun 2019 | A1 |
20190192066 | Schoess et al. | Jun 2019 | A1 |
20190231939 | Askem et al. | Aug 2019 | A1 |
20190290496 | Brownhill et al. | Sep 2019 | A1 |
20200147407 | Efremkin | May 2020 | A1 |
20200330258 | Hansen et al. | Oct 2020 | A1 |
Number | Date | Country |
---|---|---|
105232229 | Jan 2016 | CN |
105395184 | Mar 2016 | CN |
106102322 | Nov 2016 | CN |
10 2012 211015 | Jan 2014 | DE |
102013 013013 | Feb 2015 | DE |
2 005 886 | Dec 2008 | EP |
2 454 990 | May 2012 | EP |
2 565 630 | Mar 2013 | EP |
2 574 275 | Apr 2013 | EP |
1 734 858 | Jul 2014 | EP |
3034054 | Jun 2016 | EP |
3 231 478 | Oct 2017 | EP |
3 409 190 | Dec 2018 | EP |
3 499 510 | Jun 2019 | EP |
1476894 | Jun 1977 | GB |
2316171 | Feb 1998 | GB |
2563602 | Dec 2018 | GB |
2009-225863 | Oct 2009 | JP |
10 2012 0119523 | Oct 2012 | KR |
101224629 | Jan 2013 | KR |
10 2014 0024743 | Mar 2014 | KR |
10 2014 0058041 | May 2014 | KR |
10 2016 0071044 | Jun 2016 | KR |
20190105898 | Sep 2019 | KR |
1 027 236 | Apr 2006 | NL |
WO 2000021433 | Apr 2000 | WO |
WO 2000043046 | Jul 2000 | WO |
WO 2003067229 | Aug 2003 | WO |
WO 2006041997 | Apr 2006 | WO |
WO 2007030379 | Mar 2007 | WO |
WO 2008006150 | Jan 2008 | WO |
WO 2008010604 | Jan 2008 | WO |
WO 2009052607 | Apr 2009 | WO |
WO 2009120951 | Oct 2009 | WO |
WO 2009141777 | Nov 2009 | WO |
WO 2010020919 | Feb 2010 | WO |
WO 2010105053 | Sep 2010 | WO |
WO 2011082420 | Jul 2011 | WO |
WO 2011113070 | Sep 2011 | WO |
WO 2011123848 | Oct 2011 | WO |
WO 2012141999 | Oct 2012 | WO |
WO 2013026999 | Feb 2013 | WO |
WO 2013044226 | Mar 2013 | WO |
WO 2013155193 | Oct 2013 | WO |
WO 2014036577 | Mar 2014 | WO |
WO 2015112095 | Jul 2015 | WO |
WO 2015168720 | Nov 2015 | WO |
WO 2016025438 | Feb 2016 | WO |
WO 2016030752 | Mar 2016 | WO |
WO 2016058032 | Apr 2016 | WO |
WO-2016073777 | May 2016 | WO |
WO 2016100218 | Jun 2016 | WO |
WO 2016109744 | Jul 2016 | WO |
WO 2016110564 | Jul 2016 | WO |
WO 2016187136 | Nov 2016 | WO |
WO 2016205872 | Dec 2016 | WO |
WO 2016205881 | Dec 2016 | WO |
WO 2017021006 | Feb 2017 | WO |
WO 2017021965 | Feb 2017 | WO |
WO 2017033058 | Mar 2017 | WO |
WO 2017037479 | Mar 2017 | WO |
WO 2017041014 | Mar 2017 | WO |
WO 2017041385 | Mar 2017 | WO |
WO 2017041386 | Mar 2017 | WO |
WO 2017041387 | Mar 2017 | WO |
WO 2017119996 | Jul 2017 | WO |
WO 2017205728 | Nov 2017 | WO |
WO 2017214188 | Dec 2017 | WO |
WO 2018035612 | Mar 2018 | WO |
WO 2018060417 | Apr 2018 | WO |
WO 2018064569 | Apr 2018 | WO |
WO 2018115461 | Jun 2018 | WO |
WO 2018144938 | Aug 2018 | WO |
WO 2018144941 | Aug 2018 | WO |
WO 2018144943 | Aug 2018 | WO |
WO 2018144946 | Aug 2018 | WO |
WO 2018162728 | Sep 2018 | WO |
WO 2018162732 | Sep 2018 | WO |
WO 2018162735 | Sep 2018 | WO |
WO 2018162736 | Sep 2018 | WO |
WO 2018185138 | Oct 2018 | WO |
WO 2018189265 | Oct 2018 | WO |
WO 2018209090 | Nov 2018 | WO |
WO 2018210692 | Nov 2018 | WO |
WO 2018210693 | Nov 2018 | WO |
WO 2018211458 | Nov 2018 | WO |
WO 2018234443 | Dec 2018 | WO |
WO 2019020550 | Jan 2019 | WO |
WO 2019020551 | Jan 2019 | WO |
WO 2019020666 | Jan 2019 | WO |
WO 2019030384 | Feb 2019 | WO |
WO 2019048624 | Mar 2019 | WO |
WO 2019048626 | Mar 2019 | WO |
WO 2019048638 | Mar 2019 | WO |
WO 2019063481 | Apr 2019 | WO |
WO 2019063488 | Apr 2019 | WO |
WO 2019067264 | Apr 2019 | WO |
WO 2019072531 | Apr 2019 | WO |
WO 2019076967 | Apr 2019 | WO |
WO 2019096828 | May 2019 | WO |
WO 2019140441 | Jul 2019 | WO |
WO 2019140444 | Jul 2019 | WO |
WO 2019140448 | Jul 2019 | WO |
WO 2019140449 | Jul 2019 | WO |
Entry |
---|
“Little Miss Plasters”, kidstravelclub.co.uk., accessed Aug. 26, 2016, in 2 pages. URL: http://www.kidstravelclub.co.uk/little-miss-girls-childrens-plasters. |
Aubakir, B. et al., “Vital Sign Monitoring Utilizing Eulerian Video Magnification and Thermography”, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Aug. 16, 2016, pp. 3527-3530, in 4 pages. |
Bandodkar, A. et al., “Battery-free, skin-interfaced microfluidic/electronic systems for simultaneous electrochemical, colorimetric, and volumetric analysis of sweat”, Science Advances, vol. 5(1), Jan. 18, 2019, in 16 pages. URL: http://advances.sciencemag.org/content/5/1/eaav3294. |
Cauwe, M. et al., “Technology development for a low-cost, roll-to-roll chip embedding solution based on PET foils”, 18th European Microelectronics and Packaging Conference (EMPC), IEEE, Sep. 12, 2011, in 6 pages. |
Farooqui, M. et al., “Low Cost Inkjet Printed Smart Bandage for Wireless Monitoring of Chronic Wounds”, Scientific Reports, vol. 6, Jun. 29, 2016, in 14 pages. |
Geng, Y. et al., “A Hybrid Low Power Biopatch for Body Surface Potential Measurement”, IEEE Journal of Biomedical and Health Informatics, vol. 17(3), May 1, 2013, XP011506375. |
Great Britain Office Action and Search Report, re GB Application No. 1703771.4, dated Aug. 29, 2017. |
Great Britain Office Action and Search Report, re GB Application No. 1703772.2, dated Aug. 11, 2017. |
Iannetta, R.A. et al., “Successful case histories of polymer based circuitry on flexible film substrates”, Electro/94 International Conference Proceedings Combined Volumes, IEEE, May 10-12, 1994, XP010149465. |
Jinto, G. et al., “Reliability of Plastic-Encapsulated Electronic Components in Supersaturated Steam Environments”, IEEE Transactions on Components, Packaging, and Manufacturing Technology, vol. 5, No. 10, Oct. 2015, in 9 pages. |
Lu, B. et al., “A study of the autofluorescence of parylene materials for [mu]TAS applications”, Lab on Chip, vol. 10, No. 14, Jul. 2010, pp. 1826-1834, in 9 pages. |
McLeod, A. et al., “Motion Magnification for Endoscopic Surgery”, Progress in Biomedical Optics and Imaging, SPIE—International Society for Optical Engineering, Mar. 12, 2014, vol. 9036, in 8 pages. |
Mostafalu, P. et al., “Wireless Flexible Smart Bandage for Continuous Monitoring of Wound Oxygenation”, IEEE Transactions on Biomedical Circuits and Systems, vol. 9, No. 5, Oct. 2015, pp. 670-677, in 8 pages. |
Narusawa, H., “The corona discharge causes short destruction that had bad influence on a power switching circuit”, Adphox Corporation, Jan. 1, 2009, in 12 pages, URL: http://www.adphox.co.jp/keisokuki/ke-english-corona/CORONA_DISCHARGE_EN.pdf. |
Raviglione, A. et al., “Real-Time Smart Textile-Based System to Monitor Pressure Offloading of Diabetic Foot Ulcers”, Journal of Diabetes Science and Technology, vol. 11, Sep. 2017, in 5 pages. |
Rose, D. et al., “Adhesive RFID Sensor Patch for Monitoring of Sweat Electrolytes”, IEEE Transactions on Biomedical Engineering, vol. 62(6), Jun. 2015 (first published Nov. 11, 2015), in 9 pages. |
Wakita, J. et al., “Variations in Optical Absorption and Fluorescence Spectra for Polyimide Thin Films Caused by Structural Isomerism”, J. Photopolym. Sci. Technol. Jan. 1, 2003, in 1 page. |
Willis, B., “Conformal Coating Inspection & Coating Faults”, Vision Engineering, Jul. 21, 2016, in 35 pages. URL: http://www.visioneng.com/wp-content/uploads/2017/11/Confirmal-Coating-Inspection-and-Defects.21JUL16.pdf. |
Willis, B., “Guide to Conformal Coating & Cleaning Defects Contents”, Mar. 1, 2014, in 31 pages. URL: http://coatingguide.smartgroup.org/Files%20pdf/Coating%20Defects%20V2%2014March2014.pdf. |
International Search Report and Written Opinion, re PCT Application No. PCT/EP2018/055945, dated Jul. 4, 2018. |
International Preliminary Report on Patentability for Application No. PCT/EP2018/055945, dated Sep. 19, 2019, 11 pages. |
Mehmood N., et al., “Applications of Modern Sensors and Wireless Technology in Effective Wound Management: Modern Sensors and Wireless Technology,” Journal of Biomedical Materials Research Part B, vol. 102, May 1, 2014, XP055739544, pp. 885-895. |
Number | Date | Country | |
---|---|---|---|
20200281513 A1 | Sep 2020 | US |